• June 16-19, 2025
  • Boston Convention & Exhibition Center

Sessions

Loading

New Pain Therapeutics: Strategies for Innovation, Investment, and Collaboration

Tuesday, June 04, 2024
Breakout Session
Next Generation Biotherapeutics
23BC
Amid the opioid crisis, urgent innovation in pain therapeutics is vital. This session addresses the opioid crisis head-on by exploring how the NIH, small biotech, biopharma, and VCs can rejuvenate CNS & pain innovation. The session will focus on pioneering strategies, boosting investment, and fostering public-private partnerships to fuel next-gen pain therapeutics and address this critical health need.
Moderator
Hernan Bazan, MD, DFSVS, FACS
CEO & Co-Founder
South Rampart Pharma, Inc.
Speakers
Emily Caporello, PhD
Program Director, Division of Translational Research
NINDS, NIH
Paige Cramer Lacatena, PhD
Director Business Development and Licensing, HQ Neurology
Merck
Ana Moreno, PhD
CEO and Founder
Navega Therapeutics
Paul Mieyal, PhD, CFA
Managing Director
Outcome Capital, LLC
Todd Bertoch, MD
Chief Executive Officer at JBR Clinical Research
CenExel
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS